Last reviewed · How we verify
NCT04104815
GI Tolerance and Acceptability of a New Thickener
NA trial testing Experimental Thickener in Gastro-intestinal Tolerance. Withdrawn.
5 February 2021
Quick facts
| Lead sponsor | Abbott Nutrition |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Start date | 5 February 2021 |
| Primary completion | 5 February 2021 |
| Estimated completion | 5 February 2021 |
Drugs / interventions tested
- Experimental Thickener
Conditions studied
- Gastro-intestinal Tolerance — all drugs for Gastro-intestinal Tolerance →
Sponsor
Abbott Nutrition — full company profile →
Who can join
18 and older, any sex, with Gastro-intestinal Tolerance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current study is designed to evaluate the gastrointestinal tolerance and acceptability of a new thickener for dysphagia patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04104815
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Abbott Nutrition trials
Trials by the same sponsor.
- NCT06709001 — An Observational Study to Assess Malnutrition Risk · completed
- NCT06368765 — Oral Rehydration Solution and Dehydration Recovery · NA · terminated
- NCT06205537 — Muscle Health and Recovery in Older Adults · NA · completed
- NCT06130475 — Oral Rehydration Solution in Healthy Adults · NA · completed
- NCT06266702 — Evaluation of a Nutritional Technology for Vitamin D Absorption · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04104815 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Nutrition
- Last refreshed: 17 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104815.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing